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ABSTRACT
The mechanisms of tumorigenesis of adrenocortical neoplasms are still
not understood. Tumor formation may be the result of spontaneous
transformation of adrenocortical cells by somatic mutatIons. Another
factor Stimulating adrenocortical cell growth and potentially associated
with formation of adrenal adenomas and, less frequently, carcinomas is
the chronic elevation of prooplomelanocortin-derived peptides in diseases
likeACTH-dependentCushing's syndromeand congenitaladrenal hyper
plasm. To further investigate the pathogenesis of adrenocortical neo
plasms, we studied the clonal composition of such tumors using X-chro
mosome inactivation analysis of the highly polymorphic region Xcen
Xpll.4 with the hybridization probe M27f3, which maps to a variable
number of tandem repeats on the X-chromosome. In addition, polymerase
chain reaction amplification of a phosphoglycerokinase gene polymor
phism was performed. After DNA extraction from tumorous adrenal
tissue and normal leukocytes in parallel, the active X-chromosome of each
sample was digested with the methylation-sensitive restriction enzyme
Hpall. A second digestion with an appropriate restriction enzyme re
vealed the polymorphism ofthe region Xcen-Xpll.4 and the phosphoglyc
erokinase locus. Whereas in normal polyclonal tissue both the paternal
and maternal alleles are detected, a monoclonal tumor shows only one of
the parental alleles. A total of2l female patients with adrenal lesions were
analyzed; 17 turned out to be heterozygous for at least one ofthe loci. Our
results were as foilows: diffuse (n = 4) and nodular (n 1) adrenal
hyperplasla In patients with ACTH-dependent Cashing's syndrome, poly
clonal pattern; adrenocortical adenomas (n 8), monoclonal (n 7), as
well as polyclonal (n = 1); adrenal carcinomas (n 3), monoclonal
pattern. One metastasis of an adrenocortical carcinoma showed a pattern
most likely due to tumor-associated loss of methylation. In the special case
ofa patient with bilateral ACTh-independent macronodular hyperplasia,
diffuse hyperplastic areas and a small nodule showed a polyclonal pattern,
whereas a large nodule was monoclonal. We conclude that most adrenal
adenomas and carcinomas are monoclonal, whereas diffuse and nodular
adrenal hyperplasias are polyclonal. The clonal composition of ACTH
Independent massive macronodular hyperplasla seems to be heterogene
ous, consisting of polyclonal and monoclonal areas.
INTRODUCTION
The pathogenesis of cancer is generally a multistep process, during
which an initiation event is followed by tumor promotion. The initi
ation event is widely regarded as a somatic mutation occurring in a
single cell, which, because of a selective growth advantage, prolifer
ates to produce a monoclonal tumor (1, 2). Adrenocortical steroid
secretion is a complex process that is regulated by several hormones
and growth factors. The hormonal control of glucocorticoid, miner
alocorticoid, and sex steroid secretion also regulates adaptive pro
cesses like hypertrophy and hyperplasia of the adrenal cortex (3, 4).
Diffuse and nodular adrenal hyperplasia has been observed in diseases
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associated with chronic elevation of proopiomelanocortin-derived
peptides like ACTH-dependent Cushing's syndrome (5) and congen
ital adrenal hyperplasia (6). Besides spontaneous transformation of
adrenocortical cells by somatic mutations, adrenocortical tumor for
mation may, therefore, be the result of chronic stimulation of the
adrenal cortex.
According to Lyon's (7) hypothesis, 1 of the 2 X-chromosomes in
all female somatic cells is functionally inactivated early in embryo
genesis by changes in the methylation pattern of cytosine residues.
This random process is fixed for a given cell and its progeny. There
fore, a roughly equal mixture of 2 types of precursor cells gives rise
to polyclonal female tissue, because some contain an active maternal,
some an active paternal X-chromosome (8). In contrast, in a neoplasm
derived from a single somatic cell, all the tumor cells would retain the
same X-inactivation pattern. In 1985, Vogelstein et a!. (9) reported the
possibility of determining clonality of human tumors based on RFLP3
of X-chromosome-linked genes like P0K or hypoxanthine phospho
ribosyltransferase. Since these RFLPs are bimorphisms, constitutional
heterozygosity may at best be 50%, but it is frequently lower. There
fore, many patients are constitutionally homozygous and uninforma
tive for assessment of tumor clonality by X-chromosome inactivation
analysis. The discovery of the highly polymorphic locus DXS255 by
Fraser et a!. (10) was a great advance because it allowed overcoming
of the limitations of X-linked RFLPs. This X-linked locus (Xcen
Xpl 1.4) shows a rate of heterozygosity of more than 90% due to the
presence of a variable number of tandem repeats (10â€”14).Recently,
Gilliland et a!. (15) developed a new polymerase chain reaction-aided
method using the polymorphism of P0K, but having the advantage of
much greater sensitivity (as few as 100 cells should be enough to
make a distinction between monoclonal and polyclonal tissue) and
avoiding the laborious Southern blot techniques.
In this study, we investigated the clonal composition of diverse
types of adrenocortical neoplasms from 21 unrelated female patients
with diverse adrenocortical neoplasms.
PATIENTS AND METHODS
Patients. Twenty-one informed and consenting female patients undergoing
adrenalectomy for various adrenocortical diseases were analyzed for heterozy
gosity of the region Xcen-Xpll.4 and the P0K locus. Patients were diagnosed
by standard clinical, biochemical, imaging, and histological criteria. The
clinical data are summarized in Table 1. The protocol was approved by the
ethics review committees of the University of Wurzburg and the National
Institute of Child Health and Human Development.
Tissue and DNA Preparation. Sources of normal DNA were whole blood
leukocytes and, whenever possible, normal adrenal or other normal tissues.
Tumors and tissue samples were frozen in liquid nitrogen immediately after
surgery and stored at â€”80Â°C.To avoid contamination with surrounding tissue
(like capsule- or fat tissue), nonneoplastic areas were removed macroscopically
and only a central part of each tissue specimen was used. DNA was isolated
from blood and tissues, as described previously (16). After quantification of
the DNA content by photometric measurement, an undigested aliquot of the
3 The abbreviations used are: RFLP, restriction fragment length polymorphism; P0K,
phosphoglycerokinase; PCR, polymerase chain reaction.
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Table 1 Clinical data of the patientsstudiedPatient
Ageno.
(yrs) Clinical presentation Hormonal status Histology of adrenocorticalneoplasia1
29 Ectopic ACTH syndrome Hypercortisolism Diffuse and focal nodular hyperplasia
2 33 Pituitary-dependent Cushing's syndrome Hypercortisolism Bilateral diffuse hyperplasia
3 52 Pituitary-dependent Cushing's syndrome Hypercortisolism Diffusehyperplasia4
31 Ectopic ACFH syndrome Hypercortisolism Diffusehyperplasia5
37 Pituitary-dependent Cushing's syndrome Hypercortisolism Bilateral nodular hyperplasia; dominantnodu e(0
2cm)6
53 Conn's syndrome Primary hyperaldosteronism Adrenal adenoma (0 3cm)7
49 Adrenal Cushing's syndrome Hypercortisolism Adrenal adenoma (0 4cm)8
40 Conn's syndrome Primary hyperaldosteronism Adrenal adenoma (0 3 cm)
9 40 MEN I,â€•adrenal Cushing's syndrome Hypercortisolism Adrenal adenoma (0 4 cm) with atrophyofadjacent
cortex10
51 Conn's syndrome Primary hyperaldosteronism Adrenal adenoma (0 2.5cm)1
1 35 Asymptomatic incidentaloma Nonfunctional Adrenal adenoma (0 7cm)12
66 Asymptomatic tumor Nonfunctional possibly subclinical Adrenal adenoma (0 5cm)cortisol
production13
62 Asymptomatic tumor Nonfunctional Adrenal adenoma (0 2cm)14
15 MEN I, Cushing's syndrome, virilization Hypercortisolism, hyperandrogenism Metastatic adrenal carcinoma; livermetastasis(0
9cm)15
49 Conn's syndrome Primary hyperaldosteronism Adrenal carcinoma (0 9cm)16
24 Cushing's syndrome Hypercortisolism Metastatic adrenal carcinoma; lungmet stasis(0
0.5cm)17
32 ACFH-independent Cushing's syndrome Hypercortisolism Bilateral macronodular hyperplasia (0 1â€”3.5cm)a
MEN I, multiple endocrine neoplasiatype I; 0, maximum tumordiameter.sample
was electrophoresed on a 0.6% agarose gel to identify samples with X-OMAT DS films were exposed for autoradiography usingintensifyingDNA
degradation. screens at â€”80Â°Cfor 12 h to 4 days. To detect the DXS255 locus, we usedtheDNA
Digestion and Gel Electrophoresis for Southern Blot. All restric- M27f3probe,whichwas kindlyprovidedby Dr. IanCraigandDr. NeilFraser.tion
enzymes were purchased from Amersham/USB (Braunschweig, Germany) The probe was labeled with [32PJdCTP using a random primer labelingkitand
wereusedinbuffersprovidedbythemanufacturer.Enzymeswereusedat followingthe manufacturer'sprotocol(BoehringerMannheim,Mannh im,a
concentration of 3 units/pg of DNA; 30 @gof DNA from tumorous adrenalGermany).tissue
and from normal blood leukocytes were digested with PstI, ethanol- and The Ps:I-digested samples show 2 bands in heterozygous patients, repre
sodium acetate-precipitated, redissolved in H20, and split into aliquots. Two senting the maternal and paternal X-chromosomes. The PstI/MspI (a methyl
aliquots were double digested further with either MspI or HpaII, respectively, ation-nonsensitive isoschizomer of HpaII)-treated samples demonstratethewhile
one remained undigested. All 6 samples were electrophoresed on a 0.6% complete digestion of both the methylated and unmethylated allele resultinginagar s
gel for 60 to 96 h at 20 V, to obtain optimal resolutions of the alleles. 2 bands, whereas the PstI/HpaII (that distinguishes the active andinactiveHybridization,
Detection, and Interpretation. DNA was transferred by allele) digestion gives rise to 4 bands in polyclonal and 2 bands inmonoclonalcapillary
elution to nylon membranes, cross-linked by ultraviolet light (Genetissue.Link r;
Bio-Rad, MÃ¼nchen,Germany), prehybridized for 20 mm at 68Â°Cwith Amplification of the PGK Locus. Investigation of the clonalcompositionQuickhyb
solution (Stratagene, Heidelberg, Germany), and hybridized for 1 h using the PCR amplification ofthe P0K locus was performed usingpreviouslyat
68Â°Cin 10 ml hybridization solution containing salmon sperm and the described methods (15) with minor modifications. In brief, leukocyteand32P-labeled
M27@ probe in a hybridization oven. After hybridization, the tumorous DNA samples were split into halves and incubated in the presenceormembranes
were washed twice in 1X standard saline-citrate, 0.5% sodium absence of HpaII. One ,.d of HpaII digested or nondigested samples wasuseddodecyl
sulfate at room temperature, and then again 30 mm at 60Â°C.KOdak for amplification using only the internal primers of the original protocol.TheTable
2 Clonal composition of the adrenal neoplasmsDXS
255 locus
Patient
no. Histology Ratioâ€• Clonality P0Klocus1
Diffuse and focal nodular hyperplasia 1.48:1.33 1â€•P2
Bilateral diffuse hyperplasia 2.05:134 Pâ€”3
Diffuse hyperplasia 1.07:1.95 PP4
Diffuse hyperplasia 1.92:1.48 Pâ€”5
Bilateral nodularhyperplasiaMakronodular
area 3.30:2.03 Pâ€”Dominant
nodule (0 2 cm) 3.30:1.48 Pâ€”6
Adrenaladenoma 1.18:>1000 Mâ€”7
Adrenal adenoma 2.19:6.34 PP8
Adrenal adenoma â€” â€”M9
Adrenal adenoma with atrophy of adjacent cortex 1.1:>1000 MM10
Adrenal adenoma 2.72:>1000 Mâ€”1
1 Adrenal adenoma NA:>1000 Mâ€”12
Adrenal adenoma â€” â€”M13
Adrenal adenoma â€” â€”M14
Metastatic adrenal carcinoma liver metastasis 9.72'@>1O00 Mâ€”15
Adrenal carcinoma NA:>i000 Mâ€”16
Metastatic adrenal carcinoma; lung metastasis NA LOMâ€”17
Bilateral macronodularhyperplasiaDiffuse
hyperplastic ares 1.13 Pâ€”Small
nodule (0 1 cm) 2.14 Pâ€”Large
nodule (0 3.5 cm) 26.02 M â€”
CLONALCOMPOS@ONOF ADRENALTUMORS
a Allelic cleavage ratio of WBCs or normal tissue to neoplastic tissue; 0, diameter.
b p polyclonal; M, monoclonal; â€”, noninformative; NA, not available/not analyzed; LOM, loss of methylation.
C Normal allelic cleavage ratio values of whole blood leukocytes were reported to be <3.3. However, in some instances skewed values >3.3 have been described (37).
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Fig. 1. Polyclonal pattem of a diffuse adrenocor
tical hyperplasia(Lanesd-f) and monoclonalpat
tern of an adenoma (Lanesj-l) at the DXS255 locus
using the M27@ probe; leukocyte DNA of the cor
responding patients are shown in Lanes a-c and g-i,
respectively. kb, kilobase.
L-DNA Hyperplasia L-DNA
PCRproductwas afterphenolchloroform/chloroformextractionandethanol!
sodium acetate precipitation digested with Bst XI, which reveals the polymor
phism. Whereas in monoclonal tissue only one allele is present, polyclonal
tissue gives rise to 2 bands.
Rate of Heterozygosity. Leukocyte DNA from 21 patients undergoing
adrenalectomy for adrenocortical neoplasm was screened for the presence of
heterozygous polymorphisms in the DXS255 and/or P0K locus. Seventeen of
those patients turned out to be heterozygous for either the DXS255 (n = 14 of
18; 78%) or the P0K (n 7 of 21; 33%) locus. Four patients showing
heterozygous pattern for both loci were examined by both methods, resulting
in identical clonal compositions. Three patients could not be further studied at
+Pst I +Pst I +Pst I +Pst I +Pst I +Pst I +Pst I +Pst I +Pst I
+MspI+HpaII +MspI+HpaII +MspI+HpaII
the DXS255 locus, as insufficient amounts of intact high molecular weight
tumor DNA were available.
Determination of Allelic Cleavage Ratio. Autoradiographs were scanned
with a Densitometer Model Bio-Profil, Vilber Lourmat (Mone Ia VallÃ©e,
France). To determine the allelic cleavage ratio each HpalI band was compared
to its homologous PstI band according to the following formula (17):
Upper PstI band X lower HpaII band
Upper HpaII band x lower Pstlband
Reciprocal values were reported when the ratio was <1.0.
Adrenocortical Hyperplasia in ACTH-dependent Cushing's
Syndrome. Four patients with diffuse hyperplasia and one patient
_____ withmacronodularhyperplasiawerenalyzed.Thediffuseadrenal
hyperplasia samples showed a polyclonal pattern by Southern blot and
PCR-aided techniques (Fig. 1 and Table 2). In the patient with
macronodular hyperplasia, the diffuse hyperplastic area and one
dominant nodule were studied separately. Both samples showed a
polyclonal pattern (Fig. 3).
Adrenocortical Adenoma. Eight adrenocortical adenomas (3 al
dosterone-producing adenomas, 3 cortisol-producing adenomas, and 2
nonfunctional adenomas) were analyzed. Five of them were inform
ative for the DXS255 locus, 5 for the P0K gene, and 2 of of the latter
for both loci. Seven adenomas showed a monoclonal pattern (Figs. 1
and 2), whereas one cortisol-producing adenoma (Patient 7) was
interpreted as a polyclonal tumor by both techniques (Fig. 4). The
microscopic appearance of this tumor was that of a typical cortisol
producing adenoma and consisted of zona fasciculata-type and zona
â€” 9 4 kb reticularis-type cells. The ipsilateral-adjacent cortex was atrophic. The
tumor did not show any unusual histological features different from
other cortical adenomas of this series, which would explain why it was
polyclonal.
Adrenocortical Carcinoma. Three adrenocortical carcinomas
(one lung metastasis, one very large liver metastasis, and one carci
noma itself) were examined for clonality by using the polymorphism
of the DXS255 locus. The carcinoma and liver metastasis turned out
to be monoclonal, whereas the lung metastasis (Patient 15) showed a
â€œmonoclonalâ€•pattern most likely due loss of methylation at the
DXS255 locus (Fig. 5).
ACTH-independent Macronodular Hyperplasia. The case of an
ACTH-independent bilateral macronodular hyperplasia (Patient 17)
heterozygous for the RFLPs at the DXS255 locus was extensively
Diffuse Adrenal Hyperplasia Adenoma
+HpaU â€¢HpaII +HpaII@ HpaII
â€” I
b C d e f 9 h
1-DNA Hyperplasia 1-DNA Adenoma
Fig. 2. Polyclonal pattern of a diffuse adrenocortical hyperplasia (Lanes c and d) and
monoclonal pattern of an adenoma (Lanes g and h) at the P0K locus using PCR;
leukocyte DNA of the corresponding patients are shown in Lanes a and b and e and f,
respectively.
a b C d e f g h i
L-DNA Hyperplasia Nodule
Fig. 3. aonal analysis of ACFH-dependcnt macronodular hyperplasia associated with
a dominant nodule; leukocyte DNA (Lanes a-c), diffuse hyperplastic area (Lanes d-f), and
nodule (Lanes g-i). Polyclonal patterns in both adrenal specimens. kb, kilobase.
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Fig. 4. Polyclonal composition of a cortisol-pro
ducing adrenal adenoma. Left: DXS255; leukocyte
DNA (Lanes a-c), adenoma (Lanes d-f); tight: P0K
locus; leukocyte DNA (Lanes g and h), adenoma
(Lanes i and j). kb, kilobase.
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studied. The right adrenal gland showed diffuse hyperplastic areas and
many small nodules (up to 1.2 cm in diameter), whereas in the left
hyperplastic adrenal cortex one dominant nodule of 3.5 cm in diam
eter and one smaller 0.4-cm nodule were present (Fig. 6, top). His
tologically each of the nodules showed a mixture of lipid-rich and
eosinophilic compact cells. The diffuse hyperplastic areas and one
small nodule from the right adrenal were polyclonal, whereas a central
part of the dominant nodule of the left adrenal gland was monoclonal
(Fig. 6, bottom).
DISCUSSION
Adrenocortical adenomas are very frequent and can be found in
1.41â€”8.7%of unselectedautopsies(18). Most of thesetumors are
clinically silent and are incidentally detected by ultrasound or com
puted tomography performed for unrelated reasons (19). The patho
genesis of these neoplasms is still not understood. Some investigators
believe that extraadrenal factors like chronic exposure of the adrenal
cortex to proopiomelancortin-derived peptides in congenital adrenal
hyperplasia may account for the development of adrenal neoplasms
(4). On the other hand, there is overwhelming evidence that cancer is
generally the result of somatic mutations, arguing for clonal expansion
of a single transformed cell (20).
In this study, we examined the pathogenesis of adrenocortical
neoplasms by determining their clonal composition. This approach
implies that monoclonal adrenocortical neoplasms arise from a single
transformed cell, whereas polyclonal adrenal tumors would suggest
adrenal hyperplasia through extraadrenal stimuli. As our results show,
the AC'TH-dependent diffuse adrenocortical hyperplasia represents
polyclonal adrenal tissue in accordance with chronic stimulation of
the adrenal cortex. Due to its polyclonal pattern, the macronodular
form of ACTH-dependent adrenal hyperplasia is most probably a later
stage of diffuse hyperplasia, developing under the influence of long
standing endogenous hyperadrenocorticotropinism (4). Similar results
have been obtained in patients with multinodular goiters, whose
diffuse hyperplastic areas of the thyroid and small thyroid nodules
showed a polyclonal pattern. However, larger thyroid nodules in
goiters were monoclonal, arguing for autonomous and adenoma-like
growth characteristics (21). Similar findings with development of
autonomous adenomas have been described in some patients with
ACTH-dependent Cushing's syndrome, in whom biochemical evalu
ation showed a transition from pituitary-dependent to non-ACTH
dependent Cushing's syndrome (22, 23).
Our finding of monoclonality in nonfunctional and cortisol- and
aldosterone-producing adrenocortical adenomas is strong evidence for
a unicellular adrenal origin of those neoplasms. So far, mutations in
several oncogenes have been described in adrenal adenomas. Consti
tutively activating point mutations ofthe a-chain of Â°i2'the inhibiting
G-protein, were reported in 3 of 11 adrenocortical neoplasms (24).
However, in a larger series of patients, no such Gip2 mutations were
found (25). Recently, Lin et aL (26) described mutations in the p53
tumor supressor gene in adrenal adenomas. Most of the mutations
were heterozygous and affected codons not commonly found in other
tumors, especially benign ones. p53 mutations are generally a late
event in malignant tumorigenesis, and this questions the significance
of p53 mutations reported in adrenal adenomas. In a previous study of
p53 mutations in adrenocortical tumors, we found p53 mutations in 3
of 11 carcinomas and 2 of 2 adrenocortical cancer cell lines, but in
none of 5 adenomas (27).
For the obviously polyclonal adenoma, several potential caveats
must be discussed. Thus, improperly dissected tumor tissue may
contain substantial amounts of surrounding tissue or stromal cells. As
these nontumoral tissues are known to be polyclonal, this contamina
tion could lead to the incorrect pattern of polyclonality. In addition,
some neoplasms could have unusual methylation patterns through
reactivation of some inactive X-chromosome alleles. This could also
falsely suggest a polyclonal origin. Recently, Silva et a!. (28) reported
that methylation of a specific site in mammalian cell DNA is not
strictly conserved and identical in progeny cells as the Lyon (7)
hypothesis suggests, but reflects an equilibrium frequency defined by
a continual loss and gain of methyl groups. It has also been reported
that certain human tumor cell lines respond to cytotoxic chemotherapy
or radiotherapy by DNA hypermethylation (29), and this could lead to
misleading results in clonal investigation (30). In our case (Patient 7),
the tumor was large enough (4 cm in diameter) to avoid contamination
with adjacent capsule tissue. Additionally, this tumor was examined
for clonality at 2 different X-chromosomal loci, which would be
unlikely to be both affected by random demethylation through neo
plastic growth.
Interestingly, the patient with a cortisol-producing adrenocortical
+Pstl +Pstl +Pstl
6.6kb â€” +MspI +HpaII
4.4kb
Adrenocortical Carcinoma
+PslI +PstI +PslI
+Msp I +HpaII
Lung Metastasis of
Adrenocortical Carcinoma
.@, 6.6kb
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Fig. 5. Monoclonal pattern of an adrenocortical carcinoma (Lanes a-c) and the pattern
of a methylation loss in the DXS255 locus in a lung metastasis (Lanes d-f). kb, kilobase.
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IFig. 6. ACI'H-independent bilateral macronodular hyperplasia. Top:
macroscopic aspect, serial adrenal slices of right and left adrenal gland.
Bottom: polyclonal pattern in diffuse hyperplastic area (Lanes a-c) and
small nodule (Lanes d-f); monoclonal pattern with some polyclonal
contaminationof the largenodule(Lanesg-i). kb, kilobase.
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adenoma in the context of multiple endocrine neoplasia type I showed
a monoclonal pattern, which was similar to the monoclonal compo
sition of parathyroid adenomas in this entity (31).
The monoclonal pattern of adrenocortical carcinomas is not sur
prising, since these neoplasms are believed to be the result of somatic
mutation(s). Mutational changes found in adrenocortical carcinomas
affect the chromosomal loci 11q13, llpl5.S, and l'7pl3 (32). 11q13
is the locus of multiple endocrine neoplasia type I gene, and adrenal
tumors are part of this hereditary tumor syndrome (33, 34). The
Beckwith-Wiedemann syndrome, a rare familial tumor syndrome, is
characterized by paternal disomy of 1lplS.S and rearrangements of
the IGF II gene (35). Affected family members are at risk for devel
opment of nephroblastoma and adrenocortical carcinoma. The p53
tumor suppressor gene maps to l7pl3 and p53 mutations have been
described in adrenocortical cancer cell lines and carcinomas (27).
The case of a lung metastasis caused by metastatic adrenocortical
carcinoma with loss of methylation in DXS255 locus shows the
complexity of tumor growth and treatment. Prior to obtaining the
tumor sample for study, the patient had undergone various chemo
therapeutic protocols, including polychemotherapy, mitotane, and
gossypol (36), which may have affected the methylation pattern in this
tumor.
ACTH-independent bilateral macronodular hyperplasia is a rare
cause of adrenal Cushing's syndrome (37). It is characterized by low
plasma ACFH concentrations in the presence of hypercortisolism
nonsuppressible by dexamethasone. The radiological features include
bilateral hyperplasia with multiple nodules of different size. Micro
scopic examination shows besides the nodules diffuse hyperplasia of
the â€œnormalâ€•adrenal cortex. The etiopathology has so far not been
elucidated. A subgroup of these patients apparently has food-depen
dent Cushing's syndrome due to expression of the gastric inhibitory
peptide receptor in the adrenal gland (38). In our patient, the adrenal
cortex showed areas of diffuse hyperplasia, micronoduli up to 1 cm in
diameter, and a dominant nodule in one adrenal gland. The diffuse
hyperplastic area and the small nodule showed a polyclonal pattern,
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whereas the large was monoclonal. This may indicate transition from
hyperplasia to autonomous adenoma-like growth characteristics in
larger nodules of this entity.
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ADDENDUM
Recently, C. Gicquel, M. Leblond-Francillard, X. Bertagna et a!. (Clonal
analysis of human adrenocortical carcinomas and secreting adenomas. Chin.
Endocrinol., 40: 465â€”477,1994) found monoclonal composition of 4 adrenal
carcinomas, polyclonality of 6 of 14 adrenal adenomas, and different clonal
patterns in different nodules of a bilateral macronodular hyperplasia.
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